Therapeutic potential of curcumin in diabetic complications
暂无分享,去创建一个
Amirhossein Sahebkar | A. Sahebkar | A. Bahrami | Afsane Bahrami | N. Parsamanesh | M. Moossavi | A. Butler | Negin Parsamanesh | Maryam Moossavi | Alexandra E. Butler | Negin Parsamanesh
[1] M. Stevens,et al. Antioxidants attenuate early up regulation of retinal vascular endothelial growth factor in streptozotocin-diabetic rats , 2001, Diabetologia.
[2] A. Sahebkar,et al. Curcumin, hemostasis, thrombosis, and coagulation , 2018, Journal of cellular physiology.
[3] Gianni Virgili,et al. Optical coherence tomography (OCT) for detection of macular oedema in patients with diabetic retinopathy. , 2011, The Cochrane database of systematic reviews.
[4] E. Krebs,et al. The MAPK signaling cascade , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[5] H. El-Garhy,et al. The potential effect of garlic extract and curcumin nanoparticles against complication accompanied with experimentally induced diabetes in rats. , 2018, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[6] H. Cohly,et al. Effect of turmeric, turmerin and curcumin on H2O2-induced renal epithelial (LLC-PK1) cell injury. , 1998, Free radical biology & medicine.
[7] Ning Zhang,et al. Stimulation of apical and basolateral VEGF-A and VEGF-C secretion by oxidative stress in polarized retinal pigment epithelial cells. , 2006, Molecular vision.
[8] V. Menon,et al. Quercetin allievates oxidative stress in streptozotocin‐induced diabetic rats , 2004, Phytotherapy research : PTR.
[9] L. Howells,et al. Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-κB activation via the NIK/IKK signalling complex , 1999, Oncogene.
[10] T. Wieman,et al. Treatment of Hyperesthetic Neuropathic Pain in Diabetics Decompression of the Tarsal Tunnel , 1995, Annals of surgery.
[11] Peiqing Liu,et al. Curcumin ameliorates diabetic nephropathy by inhibiting the activation of the SphK1-S1P signaling pathway , 2013, Molecular and Cellular Endocrinology.
[12] D. Hardie,et al. AMPK: a nutrient and energy sensor that maintains energy homeostasis , 2012, Nature Reviews Molecular Cell Biology.
[13] M. Bhattacharya,et al. Curcumin as potential therapeutic natural product: a nanobiotechnological perspective , 2016, The Journal of pharmacy and pharmacology.
[14] Wei Wu,et al. Effect of curcumin on rats/mice with diabetic nephropathy: a systematic review and meta-analysis of randomized controlled trials. , 2014, Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan.
[15] Zhi-Li Huang,et al. Curcumin exerts antinociceptive effects in a mouse model of neuropathic pain: Descending monoamine system and opioid receptors are differentially involved , 2012, Neuropharmacology.
[16] R. Leibel,et al. Dietary curcumin significantly improves obesity-associated inflammation and diabetes in mouse models of diabesity. , 2008, Endocrinology.
[17] R. Kumar,et al. Inhibition of ligand-induced activation of epidermal growth factor receptor tyrosine phosphorylation by curcumin. , 1995, Carcinogenesis.
[18] D. Pradhan,et al. Pharmacognostic Evaluation of Curcumin on Diabetic Retinopathy in Alloxan-induced Diabetes through NF-KB and Brn3a Related Mechanism , 2018 .
[19] E. Wang,et al. Curcumin Ameliorates Diabetic Nephropathy by Suppressing NLRP3 Inflammasome Signaling , 2017, BioMed research international.
[20] S. Chakrabarti,et al. Curcumin prevents diabetes-associated abnormalities in the kidneys by inhibiting p300 and nuclear factor-kappaB. , 2009, Nutrition.
[21] S. Asgary,et al. Treatment of Non‐alcoholic Fatty Liver Disease with Curcumin: A Randomized Placebo‐controlled Trial , 2016, Phytotherapy research : PTR.
[22] Kaili Wu,et al. Curcumin Alleviates Diabetic Retinopathy in Experimental Diabetic Rats , 2018, Ophthalmic Research.
[23] S. T. Hosseini,et al. Cancer chemopreventive activity of diversin from Ferula diversivittata in vitro and in vivo. , 2010, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[24] Chao Liu,et al. Curcumin Alleviates Diabetic Cardiomyopathy in Experimental Diabetic Rats , 2012, PloS one.
[25] Liping Huang,et al. Chronic sphingosine 1-phosphate 1 receptor activation attenuates early-stage diabetic nephropathy independent of lymphocytes. , 2011, Kidney international.
[26] M. Czaja. JNK regulation of hepatic manifestations of the metabolic syndrome , 2010, Trends in Endocrinology & Metabolism.
[27] A. Bansal,et al. SNEDDS curcumin formulation leads to enhanced protection from pain and functional deficits associated with diabetic neuropathy: an insight into its mechanism for neuroprotection. , 2013, Nanomedicine : nanotechnology, biology, and medicine.
[28] K. Srinivasan,et al. Amelioration of renal lesions associated with diabetes by dietary curcumin in streptozotocin diabetic rats , 1998, Molecular and Cellular Biochemistry.
[29] Bo-hou Xia,et al. Curcumin , 2020, Medicine.
[30] Z. Ali. EVALUATION OF ANTI-DIABETIC AND NEPHRO PROTECTIVE ACTIVITY OF 95% ETHANOLIC EXTRACT OF CANTHIUM DICOCCUM WHOLE PLANT BY USING ALBINO RATS , 2013 .
[31] A. Sahebkar,et al. Immune modulation by curcumin: The role of interleukin-10 , 2019, Critical reviews in food science and nutrition.
[32] H. Kamiya,et al. Insulin, C-peptide, hyperglycemia, and central nervous system complications in diabetes. , 2004, European journal of pharmacology.
[33] Jun-Li Liu,et al. Curcumin and Diabetes: A Systematic Review , 2013, Evidence-based complementary and alternative medicine : eCAM.
[34] E. Skrzypczak‐Jankun,et al. Plasminogen activator inhibitor-1 in kidney pathology (Review). , 2013, International journal of molecular medicine.
[35] C. Pollock,et al. Increased sphingosine 1‐phosphate mediates inflammation and fibrosis in tubular injury in diabetic nephropathy , 2016, Clinical and Experimental Pharmacology and Physiology.
[36] H. Haller,et al. Diminished loss of proteoglycans and lack of albuminuria in protein kinase C-alpha-deficient diabetic mice. , 2004, Diabetes.
[37] Wei Sun,et al. Huangkui capsule attenuates renal fibrosis in diabetic nephropathy rats through regulating oxidative stress and p38MAPK/Akt pathways, compared to α-lipoic acid. , 2015, Journal of ethnopharmacology.
[38] P. Suryanarayana,et al. Effect of curcumin on hyperglycemia-induced vascular endothelial growth factor expression in streptozotocin-induced diabetic rat retina. , 2007, Biochemical and biophysical research communications.
[39] C. Rao,et al. Curcumin protects retinal cells from light-and oxidant stress-induced cell death. , 2009, Free radical biology & medicine.
[40] F. Braet,et al. KCa3.1 mediates dysfunction of tubular autophagy in diabetic kidneys via PI3k/Akt/mTOR signaling pathways , 2016, Scientific Reports.
[41] Peipei Wang,et al. Curcumin Attenuates Retinal Vascular Leakage by Inhibiting Calcium/Calmodulin-Dependent Protein Kinase II Activity in Streptozotocin-Induced Diabetes , 2016, Cellular Physiology and Biochemistry.
[42] A. Gaikwad,et al. Change in post‐translational modifications of histone H3, heat‐shock protein‐27 and MAP kinase p38 expression by curcumin in streptozotocin‐induced type I diabetic nephropathy , 2008, British journal of pharmacology.
[43] B. Davis,et al. Cardiovascular and Renal Outcomes of Renin–Angiotensin System Blockade in Adult Patients with Diabetes Mellitus: A Systematic Review with Network Meta-Analyses , 2016, PLoS medicine.
[44] A. Sahebkar,et al. Effects of Curcuminoids Plus Piperine on Glycemic, Hepatic and Inflammatory Biomarkers in Patients with Type 2 Diabetes Mellitus: A Randomized Double-Blind Placebo-Controlled Trial , 2018, Drug Research.
[45] Kenji Suzuki,et al. Curcumin attenuates diabetic nephropathy by inhibiting PKC-α and PKC-β1 activity in streptozotocin-induced type I diabetic rats. , 2011, Molecular nutrition & food research.
[46] N. Calcutt,et al. A novel curcumin derivative for the treatment of diabetic neuropathy , 2018, Neuropharmacology.
[47] K. Dua,et al. Minocycline attenuates the development of diabetic neuropathic pain: possible anti-inflammatory and anti-oxidant mechanisms. , 2011, European journal of pharmacology.
[48] K. Srinivasan,et al. Hypolipidemic action of curcumin, the active principle of turmeric (Curcuma longa) in streptozotocin induced diabetic rats , 2004, Molecular and Cellular Biochemistry.
[49] A. Straube,et al. TNF-alpha expression in painful and nonpainful neuropathies , 2001, Neurology.
[50] M. Ghanei,et al. Effects of Curcuminoids-Piperine Combination on Systemic Oxidative Stress, Clinical Symptoms and Quality of Life in Subjects with Chronic Pulmonary Complications Due to Sulfur Mustard: A Randomized Controlled Trial , 2016, Journal of dietary supplements.
[51] Mi-Kyung Lee,et al. Effect of curcumin supplementation on blood glucose, plasma insulin, and glucose homeostasis related enzyme activities in diabetic db/db mice. , 2008, Molecular nutrition & food research.
[52] Y. Panahi,et al. Mitigation of Systemic Oxidative Stress by Curcuminoids in Osteoarthritis: Results of a Randomized Controlled Trial , 2016, Journal of dietary supplements.
[53] Beverley Balkau,et al. The prevalence of and factors associated with diabetic retinopathy in the Australian population. , 2003, Diabetes care.
[54] L. Gesualdo,et al. Pathogenetic mechanisms of diabetic nephropathy. , 2005, Journal of the American Society of Nephrology : JASN.
[55] D. Ziegler. Treatment of Diabetic Polyneuropathy , 2006, Annals of the New York Academy of Sciences.
[56] S. Sang,et al. Modulation of arachidonic acid metabolism by curcumin and related β-diketone derivatives: effects on cytosolic phospholipase A2, cyclooxygenases and 5-lipoxygenase , 2004 .
[57] Eva L Feldman,et al. Diabetic neuropathy: clinical manifestations and current treatments , 2012, The Lancet Neurology.
[58] G. Dolcini,et al. Two immunomodulators, curcumin and sulfasalazine, enhance IDV antiretroviral activity in HIV-1 persistently infected cells , 2008, Archives of Virology.
[59] Yinfei Yu,et al. Effects of a novel curcumin derivative on the functions of kidney in streptozotocin-induced type 2 diabetic rats , 2018, Inflammopharmacology.
[60] Michael Brownlee,et al. The pathobiology of diabetic complications: a unifying mechanism. , 2005, Diabetes.
[61] Kenji Suzuki,et al. Molecular understanding of curcumin in diabetic nephropathy. , 2013, Drug discovery today.
[62] N. Cooper,et al. Glutamate-induced NFkappaB activation in the retina. , 2009, Investigative ophthalmology & visual science.
[63] P. Sil,et al. Curcumin enhances recovery of pancreatic islets from cellular stress induced inflammation and apoptosis in diabetic rats. , 2015, Toxicology and applied pharmacology.
[64] I. Benter,et al. Inhibition of calcium/calmodulin-dependent protein kinase II normalizes diabetes-induced abnormal vascular reactivity in the rat perfused mesenteric vascular bed. , 2003, Autonomic & autacoid pharmacology.
[65] A. Sahebkar,et al. Curcumin downregulates human tumor necrosis factor-α levels: A systematic review and meta-analysis ofrandomized controlled trials. , 2016, Pharmacological research.
[66] A. Sahebkar,et al. Therapeutic effects of curcumin in inflammatory and immune‐mediated diseases: A nature‐made jack‐of‐all‐trades? , 2018, Journal of cellular physiology.
[67] Stefan Scholl,et al. Pathophysiology of Macular Edema , 2010, Ophthalmologica.
[68] L. Pari,et al. Tetrahydrocurcumin prevents brain lipid peroxidation in streptozotocin-induced diabetic rats. , 2007, Journal of medicinal food.
[69] Thomas H Marwick,et al. Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. , 2004, Endocrine reviews.
[70] K. Chopra,et al. Tocotrienol attenuates oxidative–nitrosative stress and inflammatory cascade in experimental model of diabetic neuropathy , 2009, Neuropharmacology.
[71] M. Lorenzi,et al. Increased expression of basement membrane collagen in human diabetic retinopathy. , 1994, The Journal of clinical investigation.
[72] T. Nakaki,et al. Static Pressure Regulates Connective Tissue Growth Factor Expression in Human Mesangial Cells* 210 , 2001, The Journal of Biological Chemistry.
[73] C. Gerhardinger,et al. Müller cell changes in human diabetic retinopathy. , 1998, Diabetes.
[74] Kenji Suzuki,et al. Curcumin ameliorates macrophage infiltration by inhibiting NF-κB activation and proinflammatory cytokines in streptozotocin induced-diabetic nephropathy , 2011, Nutrition & metabolism.
[75] K. Chopra,et al. Curcumin attenuates thermal hyperalgesia in a diabetic mouse model of neuropathic pain. , 2006, European journal of pharmacology.
[76] R. Foresti,et al. Curcumin, an antioxidant and anti-inflammatory agent, induces heme oxygenase-1 and protects endothelial cells against oxidative stress. , 2000, Free radical biology & medicine.
[77] V. Menon,et al. Protective effect of tetrahydrocurcumin and chlorogenic acid against streptozotocin–nicotinamide generated oxidative stress induced diabetes , 2010 .
[78] T. Wada,et al. Involvement of extracellular signal-regulated kinase and p38 in human diabetic nephropathy. , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[79] N. Kawai,et al. Hyperglycemia induces progressive changes in the cerebral microvasculature and blood-brain barrier transport during focal cerebral ischemia. , 1998, Acta neurochirurgica. Supplement.
[80] I. Zagon,et al. Use of topical insulin to normalize corneal epithelial healing in diabetes mellitus. , 2007, Archives of ophthalmology.
[81] Y. Panahi,et al. Curcumin Lowers Serum Lipids and Uric Acid in Subjects With Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial , 2016, Journal of cardiovascular pharmacology.
[82] A. Ahmed,et al. Protective effects of combined therapy of gliclazide with curcumin in experimental diabetic neuropathy in rats , 2012, Behavioural pharmacology.
[83] G. Cho,et al. CaMKII regulates pericyte loss in the retina of early diabetic mouse , 2011, Molecules and cells.
[84] G. Liang,et al. Inhibition of high glucose-induced inflammation and fibrosis by a novel curcumin derivative prevents renal and heart injury in diabetic mice. , 2017, Toxicology letters.
[85] B. Gallacher,et al. Glucose-Induced Protein Kinase C Activation Regulates Vascular Permeability Factor mRNA Expression and Peptide Production by Human Vascular Smooth Muscle Cells In Vitro , 1997, Diabetes.
[86] N. Alenina,et al. The ACE2/Angiotensin-(1–7)/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1–7) , 2017, Physiological reviews.
[87] L. Cai,et al. Novel curcumin analog C66 prevents diabetic nephropathy via JNK pathway with the involvement of p300/CBP-mediated histone acetylation. , 2015, Biochimica et biophysica acta.
[88] D. Hardie,et al. AMPK: A Target for Drugs and Natural Products With Effects on Both Diabetes and Cancer , 2013, Diabetes.
[89] S. Jirawatnotai,et al. Reduction of atherogenic risk in patients with type 2 diabetes by curcuminoid extract: a randomized controlled trial. , 2014, The Journal of nutritional biochemistry.
[90] Afaf D. Abdel-Mageida,et al. The potential e ff ect of garlic extract and curcumin nanoparticles against complication accompanied with experimentally induced diabetes in rats , 2018 .
[91] Hai-yan Chi,et al. Effect of curcumin on glucose and lipid metabolism, FFAs and TNF-α in serum of type 2 diabetes mellitus rat models , 2017, Saudi journal of biological sciences.
[92] B. Aggarwal,et al. Curcumin (Diferuloylmethane) inhibition of tumor necrosis factor (TNF)-mediated adhesion of monocytes to endothelial cells by suppression of cell surface expression of adhesion molecules and of nuclear factor-kappaB activation. , 1998, Biochemical pharmacology.
[93] A. Sahebkar,et al. Turmeric (Curcuma longa) and its major constituent (curcumin) as nontoxic and safe substances: Review , 2018, Phytotherapy research : PTR.
[94] K. Chopra,et al. Curcumin attenuates diabetic encephalopathy in rats: behavioral and biochemical evidences. , 2007, European journal of pharmacology.
[95] K. Chopra,et al. CURCUMIN, THE ACTIVE PRINCIPLE OF TURMERIC (CURCUMA LONGA), AMELIORATES DIABETIC NEPHROPATHY IN RATS , 2006, Clinical and experimental pharmacology & physiology.
[96] Xiaokun Li,et al. Inhibition of high glucose‐induced inflammatory response and macrophage infiltration by a novel curcumin derivative prevents renal injury in diabetic rats , 2012, British journal of pharmacology.
[97] S. Gautam,et al. Curcumin, a compound with anti-inflammatory and anti-oxidant properties, down-regulates chemokine expression in bone marrow stromal cells. , 1997, Experimental hematology.
[98] Y. Panahi,et al. Antioxidant and anti-inflammatory effects of curcuminoid-piperine combination in subjects with metabolic syndrome: A randomized controlled trial and an updated meta-analysis. , 2015, Clinical nutrition.
[99] D. Panagiotakos,et al. Lipid lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel# , 2017, Archives of medical science : AMS.
[100] Anupama E. Gururaj,et al. Molecular mechanisms of anti-angiogenic effect of curcumin. , 2002, Biochemical and biophysical research communications.
[101] Xianggen Wu,et al. Intranasal delivery of nanomicelle curcumin promotes corneal epithelial wound healing in streptozotocin-induced diabetic mice , 2016, Scientific Reports.
[102] De-bao Liu,et al. Curcumin Attenuates Diabetic Neuropathic Pain by Downregulating TNF-α in a Rat Model , 2013, International journal of medical sciences.
[103] B. Viollet,et al. A role for AMP-activated protein kinase in diabetes-induced renal hypertrophy. , 2007, American journal of physiology. Renal physiology.
[104] P. Murugan,et al. Antioxidant effect of tetrahydrocurcumin in streptozotocin-nicotinamide induced diabetic rats. , 2006, Life sciences.
[105] G. King,et al. Characterization of protein kinase C beta isoform activation on the gene expression of transforming growth factor-beta, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats. , 1997, The Journal of clinical investigation.
[106] Lea Joanne DeLoughery,et al. RAGE , 2018, Springer Reference Medizin.
[107] R. Atkins,et al. Abnormal p38 mitogen-activated protein kinase signalling in human and experimental diabetic nephropathy , 2004, Diabetologia.
[108] J. Jakobsen. Treatment of diabetic polyneuropathy , 1992, Acta neurologica Scandinavica.
[109] M. Nazıroğlu,et al. Role of Oxidative Stress and Ca2+ Signaling on Molecular Pathways of Neuropathic Pain in Diabetes: Focus on TRP Channels , 2012, Neurochemical Research.
[110] M. Zou,et al. Regulation of interplay between autophagy and apoptosis in the diabetic heart , 2013, Autophagy.
[111] Y. Liu,et al. Curcumin upregulates transcription factor Nrf2, HO-1 expression and protects rat brains against focal ischemia , 2009, Brain Research.
[112] S. Ryter,et al. The Heme Oxygenase-1/Carbon Monoxide Pathway Suppresses TLR4 Signaling by Regulating the Interaction of TLR4 with Caveolin-11 , 2009, The Journal of Immunology.
[113] Zhong-fu Zuo,et al. Protective effects of curcumin on retinal Müller cell in early diabetic rats. , 2013, International journal of ophthalmology.
[114] M. Hanani. Satellite glial cells in sensory ganglia: from form to function , 2005, Brain Research Reviews.
[115] T. Orchard,et al. Psychomotor Slowing Is Associated With Distal Symmetrical Polyneuropathy in Adults With Diabetes Mellitus , 1992, Diabetes.
[116] Mi Young Lee,et al. Protective Effects of Curcumin on Renal Oxidative Stress and Lipid Metabolism in a Rat Model of Type 2 Diabetic Nephropathy , 2016, Yonsei medical journal.
[117] Sayon Roy,et al. Downregulation of fibronectin overexpression reduces basement membrane thickening and vascular lesions in retinas of galactose-fed rats. , 2003, Diabetes.
[118] K. Chopra,et al. Effect of insulin and its combination with resveratrol or curcumin in attenuation of diabetic neuropathic pain: participation of nitric oxide and TNF‐alpha , 2007, Phytotherapy research : PTR.
[119] G. Horton,et al. Flat-mount studies of human retinal vessels. , 1966, American journal of ophthalmology.
[120] Thomas de Quincey. [C] , 2000, The Works of Thomas De Quincey, Vol. 1: Writings, 1799–1820.
[121] G. Belcaro,et al. Meriva®, a lecithinized curcumin delivery system, in diabetic microangiopathy and retinopathy. , 2012, Panminerva medica.
[122] Chunping Zhang,et al. Nanoparticle-Encapsulated Curcumin Inhibits Diabetic Neuropathic Pain Involving the P2Y12 Receptor in the Dorsal Root Ganglia , 2018, Front. Neurosci..
[123] E. Travis Littledike,et al. Insulin , 1923, The Indian medical gazette.
[124] Guowang Xu,et al. Study of urinary 8-hydroxydeoxyguanosine as a biomarker of oxidative DNA damage in diabetic nephropathy patients. , 2004, Journal of pharmaceutical and biomedical analysis.
[125] Tsuyoshi Murata,et al. {m , 1934, ACML.
[126] A. Lin. Activation of the JNK signaling pathway: Breaking the brake on apoptosis , 2003, BioEssays : news and reviews in molecular, cellular and developmental biology.
[127] Y. Ohashi,et al. Higher incidence of diabetic nephropathy in type 2 than in type 1 diabetes in early-onset diabetes in Japan. , 2000, Kidney international.
[128] H. Kishida,et al. Hypoglycemic effects of turmeric (Curcuma longa L. rhizomes) on genetically diabetic KK-Ay mice. , 2005, Biological & pharmaceutical bulletin.
[129] B. Li,et al. Ocular surface changes in type II diabetic patients with proliferative diabetic retinopathy. , 2015, International journal of ophthalmology.
[130] P. Salimath,et al. Antidiabetic property of fenugreek seed mucilage and spent turmeric in streptozotocin-induced diabetic rats , 2005 .
[131] S. Yim,et al. Curcumin suppresses lipopolysaccharide-induced cyclooxygenase-2 expression by inhibiting activator protein 1 and nuclear factor kappab bindings in BV2 microglial cells. , 2004, Journal of pharmacological sciences.
[132] Timothy S Kern,et al. Activation of nuclear factor-kappaB induced by diabetes and high glucose regulates a proapoptotic program in retinal pericytes. , 2002, Diabetes.
[133] David R Webb,et al. Pathophysiology of type 1 and type 2 diabetes mellitus: a 90-year perspective , 2015, Postgraduate Medical Journal.
[134] H. Makino,et al. Involvement of MAPKs in ICAM-1 expression in glomerular endothelial cells in diabetic nephropathy. , 2011, Acta medica Okayama.
[135] J. Tang,et al. Abnormalities of retinal metabolism in diabetes and experimental galactosemia. VII. Effect of long-term administration of antioxidants on the development of retinopathy. , 2001, Diabetes.
[136] D. Zochodne. Diabetes mellitus and the peripheral nervous system: Manifestations and mechanisms , 2007, Muscle & nerve.
[137] H. Parving,et al. Decreasing incidence of severe diabetic microangiopathy in type 1 diabetes. , 2003, Diabetes care.
[138] A. Sahebkar,et al. Curcumin as a natural regulator of monocyte chemoattractant protein-1. , 2017, Cytokine & growth factor reviews.
[139] L. Pari,et al. Influence of tetrahydrocurcumin on erythrocyte membrane bound enzymes and antioxidant status in experimental type 2 diabetic rats. , 2007, Journal of ethnopharmacology.
[140] W. Ling,et al. Curcumin attenuates Nrf2 signaling defect, oxidative stress in muscle and glucose intolerance in high fat diet-fed mice. , 2012, World journal of diabetes.
[141] R. Baron,et al. Translation of symptoms and signs into mechanisms in neuropathic pain , 2003, Pain.
[142] Hong-Zhuan Chen,et al. Phosphorylated heat shock protein 27 is involved in enhanced heart tolerance to ischemia in short-term type 1 diabetic rats , 2005, Acta Pharmacologica Sinica.
[143] R. Frank. Diabetic Retinopathy and Systemic Factors , 2015, Middle East African journal of ophthalmology.
[144] A. Kashiwagi,et al. Protein Kinase Cβ Selective Inhibitor LY333531 Attenuates Diabetic Hyperalgesia Through Ameliorating cGMP Level of Dorsal Root Ganglion Neurons , 2003 .
[145] A. Straube,et al. TNF-alpha expression in painful and nonpainful neuropathies , 2001, Neurology.
[146] Y. Panahi,et al. Antioxidant effects of curcuminoids in patients with type 2 diabetes mellitus: a randomized controlled trial , 2016, Inflammopharmacology.
[147] V. Bril. Treatments for diabetic neuropathy , 2012, Journal of the peripheral nervous system : JPNS.
[148] S. Chakrabarti,et al. Genotoxic stress and activation of novel DNA repair enzymes in human endothelial cells and in the retinas and kidneys of streptozotocin diabetic rats , 2012, Diabetes/metabolism research and reviews.
[149] R. Pop-Busui,et al. Neuropathy in the DCCT/EDIC-What Was Done Then and What We Would Do Better Now. , 2016, International review of neurobiology.
[150] B. Aggarwal,et al. Activation of Transcription Factor NF-κB Is Suppressed by Curcumin (Diferuloylmethane) (*) , 1995, The Journal of Biological Chemistry.
[151] D. Zochodne,et al. RAGE, diabetes, and the nervous system. , 2007, Current molecular medicine.
[152] Kenji Suzuki,et al. Curcumin decreases renal triglyceride accumulation through AMPK-SREBP signaling pathway in streptozotocin-induced type 1 diabetic rats. , 2013, The Journal of nutritional biochemistry.
[153] V. Menon,et al. Effect of photo-irradiated curcumin treatment against oxidative stress in streptozotocin-induced diabetic rats. , 2005, Journal of medicinal food.
[154] E. Cagliero,et al. Characteristics and Mechanisms of High-Glucose–Induced Overexpression of Basement Membrane Components in Cultured Human Endothelial Cells , 1991, Diabetes.
[155] Y. D. Reijmer,et al. A 4 year follow-up study of cognitive functioning in patients with type 2 diabetes mellitus , 2009, Diabetologia.
[156] Yunes Panahi,et al. Curcuminoids modify lipid profile in type 2 diabetes mellitus: A randomized controlled trial. , 2017, Complementary therapies in medicine.
[157] S. Tesfaye,et al. Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy , 2001, Diabetologia.
[158] D. Cui,et al. Interleukin-22 ameliorated renal injury and fibrosis in diabetic nephropathy through inhibition of NLRP3 inflammasome activation , 2017, Cell Death & Disease.
[159] A. Sahebkar,et al. Curcumin: A new candidate for melanoma therapy? , 2016, International journal of cancer.
[160] H. Banafshe,et al. Effect of curcumin on diabetic peripheral neuropathic pain: possible involvement of opioid system. , 2014, European journal of pharmacology.
[161] A. Masamune,et al. Curcumin blocks activation of pancreatic stellate cells , 2006, Journal of cellular biochemistry.
[162] S. Adler,et al. Curcumin activates the p38MPAK-HSP25 pathway in vitro but fails to attenuate diabetic nephropathy in DBA2J mice despite urinary clearance documented by HPLC , 2010, BMC complementary and alternative medicine.
[163] M. Dunlop,et al. Aldose reductase and the role of the polyol pathway in diabetic nephropathy. , 2000, Kidney international. Supplement.
[164] M. Haneda,et al. J Am Soc Nephrol 14: 1374–1382, 2003 Overview of Glucose Signaling in Mesangial Cells in Diabetic Nephropathy , 2022 .
[165] A. Sahebkar,et al. Curcumin as a MicroRNA Regulator in Cancer: A Review. , 2016, Reviews of physiology, biochemistry and pharmacology.
[166] S. S. Agrawal,et al. Curcumin prevents experimental diabetic retinopathy in rats through its hypoglycemic, antioxidant, and anti-inflammatory mechanisms. , 2011, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.
[167] Naijil George,et al. Role of curcumin in the prevention of cholinergic mediated cortical dysfunctions in streptozotocin-induced diabetic rats , 2011, Molecular and Cellular Endocrinology.
[168] R. Flavell,et al. Role of MKK3–p38 MAPK signalling in the development of type 2 diabetes and renal injury in obese db/db mice , 2009, Diabetologia.
[169] Weiya Ma,et al. ERKs and p38 Kinases Mediate Ultraviolet B-induced Phosphorylation of Histone H3 at Serine 10* , 2000, The Journal of Biological Chemistry.
[170] A. Somogyi,et al. Soluble semicarbazide-sensitive amine oxidase (SSAO) activity is related to oxidative stress and subchronic inflammation in streptozotocin-induced diabetic rats , 2006, Neurochemistry International.
[171] R. Mastrocola,et al. Oxidative and nitrosative stress in brain mitochondria of diabetic rats. , 2005, The Journal of endocrinology.
[172] Xiaokun Li,et al. Targeting JNK by a New Curcumin Analog to Inhibit NF-kB-Mediated Expression of Cell Adhesion Molecules Attenuates Renal Macrophage Infiltration and Injury in Diabetic Mice , 2013, PloS one.
[173] J. Pfeilschifter,et al. Sphingosine 1-Phosphate Cross-activates the Smad Signaling Cascade and Mimics Transforming Growth Factor-β-induced Cell Responses* , 2004, Journal of Biological Chemistry.
[174] D. Jue,et al. Interleukin-18 induces the production of vascular endothelial growth factor (VEGF) in rheumatoid arthritis synovial fibroblasts via AP-1-dependent pathways. , 2006, Immunology letters.
[175] T. Kern,et al. Hyperglycemia as a cause of diabetic retinopathy. , 1986, Metabolism: clinical and experimental.
[176] R. Manikandan,et al. Ameliorative effects of curcumin against renal injuries mediated by inducible nitric oxide synthase and nuclear factor kappa B during gentamicin-induced toxicity in Wistar rats. , 2011, European journal of pharmacology.
[177] U. Pendurthi,et al. Suppression of transcription factor Egr-1 by curcumin. , 2000, Thrombosis research.
[178] C. Pollock,et al. The role of toll-like receptors in diabetic kidney disease , 2018, Current opinion in nephrology and hypertension.
[179] A. Sahebkar,et al. Analgesic Efficacy and Safety of Curcuminoids in Clinical Practice: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. , 2015, Pain medicine.
[180] L. Pari,et al. EFFECT OF TETRAHYDROCURCUMIN ON BLOOD GLUCOSE, PLASMA INSULIN AND HEPATIC KEY ENZYMES IN STREPTOZOTOCIN INDUCED DIABETIC RATS , 2005, Journal of basic and clinical physiology and pharmacology.
[181] G. Bruno,et al. Inflammation in diabetic nephropathy: moving toward clinical biomarkers and targets for treatment , 2015, Endocrine.
[182] D. Becker,et al. Mild hypoglycemia associated with deterioration of mental efficiency in children with insulin-dependent diabetes mellitus. , 1990, The Journal of pediatrics.
[183] Linda Greensmith,et al. Induction of heat shock proteins for protection against oxidative stress. , 2009, Advanced drug delivery reviews.
[184] M. Diederich,et al. Curcumin regulates signal transducer and activator of transcription (STAT) expression in K562 cells. , 2006, Biochemical pharmacology.
[185] B. Aggarwal,et al. Curcumin: an orally bioavailable blocker of TNF and other pro‐inflammatory biomarkers , 2013, British journal of pharmacology.
[186] A. Sahebkar. Molecular mechanisms for curcumin benefits against ischemic injury. , 2010, Fertility and sterility.
[187] J. Chung. The role of reactive oxygen species (ROS) in persistent pain. , 2004, Molecular interventions.
[188] Sushil K. Jain,et al. Curcumin supplementation lowers TNF-alpha, IL-6, IL-8, and MCP-1 secretion in high glucose-treated cultured monocytes and blood levels of TNF-alpha, IL-6, MCP-1, glucose, and glycosylated hemoglobin in diabetic rats. , 2009, Antioxidants & redox signaling.
[189] J. Berger,et al. Role of PPARs in the regulation of obesity-related insulin sensitivity and inflammation , 2003, International Journal of Obesity.
[190] Cheng Ho,et al. Curcumin Rescues Diabetic Renal Fibrosis by Targeting Superoxide‐Mediated Wnt Signaling Pathways§, ☆, ☆☆, ☆☆☆ , 2016, The American journal of the medical sciences.
[191] Li-na Sun,et al. Curcumin prevents diabetic nephropathy against inflammatory response via reversing caveolin-1 Tyr14 phosphorylation influenced TLR4 activation. , 2014, International immunopharmacology.
[192] M. Chan. Inhibition of tumor necrosis factor by curcumin, a phytochemical. , 1995, Biochemical pharmacology.
[193] M. James,et al. NLRP3 Localizes to the Tubular Epithelium in Human Kidney and Correlates With Outcome in IgA Nephropathy , 2016, Scientific Reports.
[194] M. Banach,et al. Curcumin: A Naturally Occurring Modulator of Adipokines in Diabetes , 2017, Journal of cellular biochemistry.
[195] Bin Zhang,et al. Curcumin ameliorated diabetic neuropathy partially by inhibition of NADPH oxidase mediating oxidative stress in the spinal cord , 2014, Neuroscience Letters.
[196] V. Menon,et al. Effect of diabetes on levels of lipid peroxides and glycolipids in rat brain. , 1993, Metabolism: clinical and experimental.
[197] H. Haller,et al. Nephrin loss in experimental diabetic nephropathy is prevented by deletion of protein kinase C alpha signaling in-vivo. , 2006, Kidney international.
[198] B. Aggarwal,et al. Curcumin: Getting Back to the Roots , 2005, Annals of the New York Academy of Sciences.
[199] M. Caraglia,et al. Vascular endothelial growth factor: An important molecular target of curcumin , 2019, Critical reviews in food science and nutrition.
[200] Li Qin,et al. Suppression of corneal neovascularization by curcumin via inhibition of Wnt/β-catenin pathway activation. , 2017, International journal of ophthalmology.
[201] H. Yamanaka,et al. Expression of ATP receptors in the rat dorsal root ganglion and spinal cord , 2012, Anatomical Science International.
[202] V. Rangnekar,et al. Suppression of growth and transformation and induction of apoptosis by EGR-1. , 1998, Cancer gene therapy.
[203] J. Baynes,et al. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. , 1999, Diabetes.
[204] A. Sahebkar,et al. Curcumin: An Effective Inhibitor of Interleukin-6. , 2017, Current pharmaceutical design.
[205] A. Gotto,et al. Lipid-modifying activity of curcuminoids: A systematic review and meta-analysis of randomized controlled trials , 2019, Critical reviews in food science and nutrition.
[206] Amirhosein Sahebkar,et al. Biological and pharmacological evaluation of dimethoxycurcumin: A metabolically stable curcumin analogue with a promising therapeutic potential , 2018, Journal of cellular physiology.
[207] H. Kishida,et al. Curcuminoids and sesquiterpenoids in turmeric (Curcuma longa L.) suppress an increase in blood glucose level in type 2 diabetic KK-Ay mice. , 2005, Journal of agricultural and food chemistry.
[208] Xiaokun Li,et al. Attenuation of high-glucose-induced inflammatory response by a novel curcumin derivative B06 contributes to its protection from diabetic pathogenic changes in rat kidney and heart. , 2013, The Journal of nutritional biochemistry.
[209] P. Suryanarayana,et al. Curcumin and turmeric delay streptozotocin-induced diabetic cataract in rats. , 2005, Investigative ophthalmology & visual science.
[210] Ju Hwan Lee,et al. Antidiabetic Potential of the Heme Oxygenase-1 Inducer Curcumin Analogues , 2013, BioMed research international.
[211] Geert Jan Biessels,et al. The effects of type 1 diabetes on cognitive performance: a meta-analysis. , 2005, Diabetes care.
[212] Matthew D. Davis,et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. , 2003, Ophthalmology.
[213] Eileen D. Adamson,et al. A zinc finger-encoding gene coregulated with c-fos during growth and differentiation, and after cellular depolarization , 1988, Cell.
[214] G. Romeo,et al. Response of capillary cell death to aminoguanidine predicts the development of retinopathy: comparison of diabetes and galactosemia. , 2000, Investigative ophthalmology & visual science.
[215] G. Yan,et al. Activation of Sphingosine Kinase-1 Mediates Inhibition of Vascular Smooth Muscle Cell Apoptosis by Hyperglycemia , 2007, Diabetes.
[216] A. Sahebkar. Curcuminoids for the management of hypertriglyceridaemia , 2014, Nature Reviews Cardiology.
[217] I. Deary,et al. Complement C3 variant and the risk of age-related macular degeneration. , 2007, The New England journal of medicine.
[218] Effect of curcuminoids on oxidative stress: A systematic review and meta-analysis of randomized controlled trials , 2015 .